We've received your inquiry. A specialist will reach out within 1 business day.
Start over
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
Announced that the Odette Cancer Centre at Sunnybrook Health Sciences Centre, a leading cancer center in Toronto, has joined BriaCell’s ongoing pivotal Phase 3 study of Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer. BriaCell Therapeutics Corp. shares T.BCT are trading down $0.12 at $5.40.
| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| BCT.TO | 4.82 | -0.28 | -5.49% |
| Briacell Therapeutics Corp | |||
/A%20Palantir%20office%20building%20in%20Tokyo_%20Image%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock_.jpg)
/BlackRock's%20global%20headquarters%20By%20Tada%20Images.jpeg)
/A%20hand%20holding%20a%20phone%20with%20the%20Reddit%20logo_%20Mamun_Sheikh%20via%20Shutterstock_.jpg)
/The%20CoreWeave%20logo%20displayed%20on%20a%20smartphone%20screen_%20Image%20by%20Robert%20Way%20via%20Shutterstock_.jpg)
/Apple%20logo%20on%20store%20front%20by%20frantic00%20via%20iStock.jpg)